comparemela.com

Latest Breaking News On - வெஸ்ட்மீட் நிறுவனம் ஆஃப் மருத்துவ ஆராய்ச்சி - Page 1 : comparemela.com

NSW spearheads key COVID-19 vaccine research

Date Time NSW spearheads key COVID-19 vaccine research ​A leading group of NSW experts will pioneer Australia-first research to inform vaccine policy in the state and beyond. The Vaccine, Infection and Immunology (VIIM) Collaborative Research Group will receive more than $4.5 million in funding from the NSW Government over three years to study the clinical and immunological responses to COVID-19 vaccines in NSW recipients. VIIM brings together the leading vaccine, infection and immunology researchers and practitioners in NSW. It incorporates expertise from two universities, four medical research institutes, the state-wide pathology service, adult and paediatric health services, and the National Centre for Immunisation Research and Surveillance.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.